143 related articles for article (PubMed ID: 11259095)
1. Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules.
Vasse M; Thibout D; Paysant J; Legrand E; Soria C; Crépin M
Br J Cancer; 2001 Mar; 84(6):802-7. PubMed ID: 11259095
[TBL] [Abstract][Full Text] [Related]
2. Sodium phenylacetate (NaPa) induces modifications of the proliferation, the adhesion and the cell cycle of tumoral epithelial breast cells.
Thibout D; Kraemer M; Di Benedetto M; Saffar L; Gattegno L; Derbin C; Crépin M
Anticancer Res; 1999; 19(3A):2121-6. PubMed ID: 10470159
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases are involved in both type I (apoptosis) and type II (autophagy) cell death induced by sodium phenylacetate in MDA-MB-231 breast tumour cells.
Augustin S; Berard M; Kellaf S; Peyri N; Fauvel-Lafève F; Legrand C; He L; Crépin M
Anticancer Res; 2009 Apr; 29(4):1335-43. PubMed ID: 19414384
[TBL] [Abstract][Full Text] [Related]
4. Aponecrotic, antiangiogenic and antiproliferative effects of a novel dextran derivative on breast cancer growth in vitro and in vivo.
Di Benedetto M; Starzec A; Colombo BM; Briane D; Perret GY; Kraemer M; Crépin M
Br J Pharmacol; 2002 Apr; 135(8):1859-71. PubMed ID: 11959788
[TBL] [Abstract][Full Text] [Related]
5. Sodium phenylacetate modulates the synthesis of autocrine and paracrine growth factors secreted by breast cancer cell lines.
Thibout D; Di Benedetto M; Kraemer M; Sainte-Catherine O; Derbin C; Crépin M
Anticancer Res; 1998; 18(4A):2657-61. PubMed ID: 9703924
[TBL] [Abstract][Full Text] [Related]
6. Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice.
Di Benedetto M; Kourbali Y; Starzec A; Vassy R; Jozefonvicz J; Perret G; Crepin M; Kraemer M
Br J Cancer; 2001 Sep; 85(6):917-23. PubMed ID: 11556846
[TBL] [Abstract][Full Text] [Related]
7. Sodium phenylacetate inhibits the Ras/MAPK signaling pathway to induce reduction of the c-Raf-1 protein in human and canine breast cancer cells.
Watanabe M; Miyajima N; Igarashi M; Endo Y; Watanabe N; Sugano S
Breast Cancer Res Treat; 2009 Nov; 118(2):281-91. PubMed ID: 18953652
[TBL] [Abstract][Full Text] [Related]
8. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
Jones JL; Shaw JA; Pringle JH; Walker RA
J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
[TBL] [Abstract][Full Text] [Related]
9. Cytostatic and pro-apoptotic effects of a novel phenylacetate-dextran derivative (NaPaC) on breast cancer cells in interactions with endothelial cells.
Malherbe S; Crépin M; Legrand C; Wei MX
Anticancer Drugs; 2004 Nov; 15(10):975-81. PubMed ID: 15514567
[TBL] [Abstract][Full Text] [Related]
10. NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP.
Lin Y; Chang G; Wang J; Jin W; Wang L; Li H; Ma L; Li Q; Pang T
Exp Cell Res; 2011 Aug; 317(14):2031-40. PubMed ID: 21669197
[TBL] [Abstract][Full Text] [Related]
11. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
[TBL] [Abstract][Full Text] [Related]
12. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
Adam L; Crépin M; Isräel L
Cancer Res; 1997 Mar; 57(6):1023-9. PubMed ID: 9067263
[TBL] [Abstract][Full Text] [Related]
13. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro.
Balduyck M; Zerimech F; Gouyer V; Lemaire R; Hemon B; Grard G; Thiebaut C; Lemaire V; Dacquembronne E; Duhem T; Lebrun A; Dejonghe MJ; Huet G
Clin Exp Metastasis; 2000; 18(2):171-8. PubMed ID: 11235993
[TBL] [Abstract][Full Text] [Related]
14. A new phenylacetate-bisphosphonate inhibits breast cancer cell growth by proapoptotic and antiangiogenic effects.
Sebbah-Louriki M; Colombo BM; el Manouni D; Martin A; Salzmann JL; Leroux Y; Perret GY; Crépin M
Anticancer Res; 2002; 22(6C):3925-31. PubMed ID: 12553014
[TBL] [Abstract][Full Text] [Related]
15. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
Götte M; Mohr C; Koo CY; Stock C; Vaske AK; Viola M; Ibrahim SA; Peddibhotla S; Teng YH; Low JY; Ebnet K; Kiesel L; Yip GW
Oncogene; 2010 Dec; 29(50):6569-80. PubMed ID: 20818426
[TBL] [Abstract][Full Text] [Related]
16. EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells.
Fox BP; Kandpal RP
Oncogene; 2009 Apr; 28(14):1706-13. PubMed ID: 19234485
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
Bachmeier BE; Nerlich AG; Lichtinghagen R; Sommerhoff CP
Anticancer Res; 2001; 21(6A):3821-8. PubMed ID: 11911253
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
19. Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors.
Kousidou OC; Mitropoulou TN; Roussidis AE; Kletsas D; Theocharis AD; Karamanos NK
Int J Oncol; 2005 Apr; 26(4):1101-9. PubMed ID: 15754008
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
